{"org_id": "T000038181", "org_name_cn": "深圳翰宇药业股份有限公司", "org_short_name_cn": "翰宇药业", "org_name_en": "Hybio Pharmaceutical Co.,Ltd.", "org_short_name_en": "HYBIO", "main_operation_business": "多肽药物研发、生产和销售。", "operating_scope": "　　经营进出口业务（法律、行政法规、国务院决定禁止的项目除外，限制的项目须取得许可后方可经营）。生产经营片剂、硬胶囊剂、颗粒剂、小容量注射剂、冻干粉针剂、原料药（按照《药品生产许可证》批准的种类生产）。", "district_encode": "440309", "org_cn_introduction": "深圳翰宇药业股份有限公司是一家专业从事多肽药物研发、生产和销售的国家级高新技术企业，公司主营产品包括特色原料药、制剂、客户定制肽、固体制剂、药品组合包装类产品和医疗器械产品六大系列。公司的主要制剂产品包括注射用胸腺五肽、注射用胸腺法新、注射用生长抑素、注射用特利加压素、注射用西曲瑞克、去氨加压素注射液、依替巴肽注射液、阿托西班注射液。公司的主要原料药包括特利加压素、依替巴肽、奥曲肽、卡贝缩宫素、缩宫素溶液、去氨加压素、鲑降钙素、生长抑素、曲普瑞林、胸腺五肽、胸腺法新原料药等。", "legal_representative": "曾少贵", "general_manager": "", "secretary": "杨笛(代)", "established_date": 1049212800000, "reg_asset": 916927040.0, "staff_num": 941, "telephone": "86-755-26588036", "postcode": "518057", "fax": "86-755-26588022", "email": "hy@hybio.com.cn", "org_website": "www.hybio.com.cn", "reg_address_cn": "广东省深圳市龙华区观澜高新园区观盛四路7号翰宇创新产业大楼", "reg_address_en": "", "office_address_cn": "广东省深圳市南山区高新技术工业园中区翰宇生物医药园办公大楼四层", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1302105600000, "provincial_name": "广东省", "actual_controller": "曾少贵 (16.75%)，曾少强 (11.67%)，曾少彬 (5.76%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "曾少贵", "executives_nums": 14, "actual_issue_vol": 25000000.0, "issue_price": 30.19, "actual_rc_net_amt": 715025800.0, "pe_after_issuing": 67.09, "online_success_rate_of_issue": 1.27854231, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}